Drugs / Cordyceps
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06601283 | Nov 2024 → Nov 2026 expected | malignant pancreatic neoplasm | Fudan University | Recruiting | No outcome recorded |
| Phase 2/3 | NCT06598033 | Nov 2024 → Oct 2026 expected | malignant pancreatic neoplasm | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cordyceps | “numerous evidence has proved the efficacy of Reishi and Cordyceps in alleviating the side effects related to chemotherapy.” NCT06598033 ↗1“Cordyceps, 2 g/day, BID, PO.” NCT06601283 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “low-dose vitamin C plus herbal medicine (Reishi and Cordyceps)” NCT06601283 ↗ |
| Route | Oral | “Cordyceps, 2 g/day, BID, PO.” NCT06598033 ↗ |